ADIM
FFIV icon

Alpha DNA Investment Management’s F5 FFIV Stock Holding History

Alpha DNA Investment Management’s Portfolio FFIV Stock Details FFIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16
Closed -$2K – 292
2021
Q1 		$2K Sell
16
-2,721
-99% -$536K ﹤0.01% 562
2020
Q4 		$481K Buy
+2,737
New +$415K 0.51% 89

Other funds holding FFIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Alpha DNA Investment Management's FFIV Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of F5 (FFIV) in Q2 2021, closing a stake of 16 shares — an estimated $2K sold.

Alpha DNA Investment Management first reported a position in FFIV in Q4 2020 and held it in 2 quarters. The position peaked at $481K in Q4 2020. 527 funds tracked by Wall St. Rank hold FFIV as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining F5 position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 16 F5 shares in Q2 2021, an estimated $2K.
  • Alpha DNA Investment Management first reported a position in F5 in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's F5 position peaked at $481K in Q4 2020.
  • 527 funds tracked by Wall St. Rank held F5 as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.